Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (28)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

  2. SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

    Frontiers in Pharmacology, Vol. 13

2021

  1. Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma

    Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337

2020

  1. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma

    PLoS ONE, Vol. 15, Núm. 9 September

  2. Wnt signaling and Loxl2 promote aggressive osteosarcoma

    Cell Research, Vol. 30, Núm. 10, pp. 885-901

2018

  1. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients

    Breast Cancer Research and Treatment, Vol. 167, Núm. 1, pp. 249-256

  2. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

    Nature Communications, Vol. 9, Núm. 1

  3. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

2017

  1. A cumulative effect involving malfunction of the PTH1R and ATP4A genes explains a familial gastric neuroendocrine tumor with hypothyroidism and arthritis

    Gastric Cancer, Vol. 20, Núm. 6, pp. 998-1003

  2. Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer

    Pharmacogenetics and Genomics, Vol. 27, Núm. 12, pp. 445-453

  3. Memory T cells expressing an NKG2D-CAR efficiently target osteosarcoma cells

    Clinical Cancer Research, Vol. 23, Núm. 19, pp. 5824-5835

  4. PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

    Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588

2016

  1. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

    Nature Communications, Vol. 7

  2. Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome

    Annals of Oncology, Vol. 27, Núm. 9, pp. 1788-1793

2015

  1. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner

    Cancer Letters, Vol. 368, Núm. 1, pp. 54-63

  2. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  3. Characterization of large structural genetic mosaicism in human autosomes

    American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497

  4. Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations

    British Journal of Haematology

  5. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients

    Journal of Medical Genetics, Vol. 52, Núm. 10, pp. 647-656